Wednesday, February 15, 2023 9:22:25 AM
2023-02-14 18:31
Fintel reports that Armistice Capital has filed a 13G/A form with the SEC disclosing ownership of 17.00MM shares of Spectrum Pharmaceuticals, Inc. (SPPI). This represents 8.37% of the company.
In their previous filing dated February 15, 2022 they reported 9.67MM shares and 5.90% of the company, an increase in shares of 75.88% and an increase in total ownership of 2.47% (calculated as current - previous percent ownership).
The projected annual revenue for Spectrum Pharmaceuticals is $46MM, a decrease of 57.97%. The projected annual EPS is -$0.26.
https://fintel.io/news/armistice-capital-now-owns-837-of-spectrum-pharmaceuticals-sppi-858
Wonder, why a decrease of 58%? Were they projecting $100M? Is it about lost Poziotinib revenue?
Recent SPPI News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 11/09/2023 10:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:27 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/26/2023 09:23:08 PM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM